Encompass Health Updates on 2025 Financial Projections

The latest update is out from Encompass Health ( (EHC) ).

Encompass Health has provided a financial update regarding its inability to predict certain non-GAAP financial measures due to factors outside its control, such as government settlements and market conditions. The company has estimated specific GAAP measures for 2025, including interest expense and amortization of debt-related items, which will be part of a reconciliation for Adjusted EBITDA.

The most recent analyst rating on (EHC) stock is a Buy with a $105.00 price target. To see the full list of analyst forecasts on Encompass Health stock, see the EHC Stock Forecast page.

Spark’s Take on EHC Stock

According to Spark, TipRanks’ AI Analyst, EHC is a Neutral.

Encompass Health’s overall stock score reflects strong financial results and strategic growth plans, bolstered by positive earnings call outcomes and strategic corporate events. However, the stock’s high valuation and technical indicators suggest investors should remain cautious of overbought conditions. While the company shows robust growth prospects, particularly with its expansion initiatives, the valuation poses a balanced risk-reward scenario.

To see Spark’s full report on EHC stock, click here.

More about Encompass Health

Average Trading Volume: 875,460

Technical Sentiment Signal: Buy

Current Market Cap: $12.18B

For an in-depth examination of EHC stock, go to TipRanks’ Stock Analysis page.